• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

促进印度抗菌药物耐药性研究。

Fostering research into antimicrobial resistance in India.

作者信息

Das Bhabatosh, Chaudhuri Susmita, Srivastava Rahul, Nair G Balakrish, Ramamurthy Thandavarayan

机构信息

Translational Health Science and Technology Institute, NCR Biotech Science Cluster, Faridabad, India

Translational Health Science and Technology Institute, NCR Biotech Science Cluster, Faridabad, India.

出版信息

BMJ. 2017 Sep 6;358:j3535. doi: 10.1136/bmj.j3535.

DOI:10.1136/bmj.j3535
PMID:28877874
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5582344/
Abstract

and colleagues discuss research and development of new antimicrobials and rapid diagnostics, which are crucial for tackling antimicrobial resistance in India

摘要

及其同事讨论了新型抗菌药物和快速诊断方法的研发，这对于应对印度的抗菌药物耐药性至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32b8/5582344/1ec68a03d633/bhad40007.f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32b8/5582344/24cfeec082c4/bhad40007.f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32b8/5582344/1ec68a03d633/bhad40007.f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32b8/5582344/24cfeec082c4/bhad40007.f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32b8/5582344/1ec68a03d633/bhad40007.f2.jpg

相似文献

1
Fostering research into antimicrobial resistance in India.促进印度抗菌药物耐药性研究。
BMJ. 2017 Sep 6;358:j3535. doi: 10.1136/bmj.j3535.
2
Highlighting the Impact of Antimicrobial Drug Resistance (AMR) in Infectious Diseases and Advocating for Improved Surveillance and Antimicrobial Stewardship Programs in Pakistan.强调抗菌药物耐药性（AMR）对巴基斯坦传染病的影响，并倡导加强监测及抗菌药物管理计划。
Asia Pac J Public Health. 2024 May;36(4):413-414. doi: 10.1177/10105395241242603. Epub 2024 Mar 30.
3
Antibiotic Stewardship in the Outpatient Setting.门诊环境中的抗生素管理
WMJ. 2017 Nov;116(4):225-227.
4
'Remarkable year' for tackling antimicrobial resistance.应对抗微生物药物耐药性的“非凡之年”。
Vet Rec. 2017 Dec;181(22):579. doi: 10.1136/vr.j5589.
5
Antimicrobial Stewardship and Antimicrobial Resistance.抗菌药物管理与抗菌药物耐药性。
Med Clin North Am. 2018 Sep;102(5):805-818. doi: 10.1016/j.mcna.2018.04.004. Epub 2018 Jul 14.
6
Access, Watch, and Reserve antibiotics in India: challenges for WHO stewardship.印度抗生素的获取、监测与储备：世卫组织管理面临的挑战
Lancet Glob Health. 2017 Nov;5(11):e1075-e1076. doi: 10.1016/S2214-109X(17)30365-0.
7
Role of Technology in Antimicrobial Stewardship.技术在抗菌药物管理中的作用。
Med Clin North Am. 2018 Sep;102(5):955-963. doi: 10.1016/j.mcna.2018.05.007. Epub 2018 Jul 14.
8
Impact of trainee-driven Antimicrobial Stewardship Program in a high burden resource-limited setting.在资源有限的高负担环境中，以学员为主导的抗菌药物管理项目的影响。
Infez Med. 2020 Sep 1;28(3):367-372.
9
Metrics of Antimicrobial Stewardship Programs.抗菌药物管理项目的衡量指标。
Med Clin North Am. 2018 Sep;102(5):965-976. doi: 10.1016/j.mcna.2018.05.008. Epub 2018 Jul 14.
10
Participatory antimicrobial stewardship: fostering patient and public engagement to counter antimicrobial resistance.参与式抗菌药物管理：促进患者和公众参与以应对抗菌药物耐药性。
Trends Microbiol. 2023 Nov;31(11):1096-1098. doi: 10.1016/j.tim.2023.07.007. Epub 2023 Aug 5.

引用本文的文献

1
A strategic approach to regulating new antimicrobials.一种监管新型抗菌药物的战略方法。
J Glob Health. 2025 Aug 18;15:03033. doi: 10.7189/jogh.15.03033.
2
Antifungal Policy and Practice Across Five Countries: A Qualitative Review.五个国家的抗真菌政策与实践：一项定性综述
J Fungi (Basel). 2025 Feb 19;11(2):162. doi: 10.3390/jof11020162.
3
Response to antimicrobial resistance in South-East Asia Region.东南亚地区对抗菌素耐药性的应对措施。

本文引用的文献

1
Antimicrobial stewardship across 47 South African hospitals: an implementation study.南非 47 家医院的抗菌药物管理：一项实施研究。
Lancet Infect Dis. 2016 Sep;16(9):1017-1025. doi: 10.1016/S1473-3099(16)30012-3. Epub 2016 Jun 14.
2
The Impact of WHO Essential Medicines Policies on Inappropriate Use of Antibiotics.世界卫生组织基本药物政策对抗生素不当使用的影响
PLoS One. 2016 Mar 22;11(3):e0152020. doi: 10.1371/journal.pone.0152020. eCollection 2016.
3
Antibiotic Resistance in India: Drivers and Opportunities for Action.印度的抗生素耐药性：驱动因素与行动机遇
Lancet Reg Health Southeast Asia. 2023 Oct 29;18:100306. doi: 10.1016/j.lansea.2023.100306. eCollection 2023 Nov.
4
Editorial: Antibiotic potentiators against drug-resistant pathogens: Discovery, development and clinical applications.社论：抗耐药病原体的抗生素增效剂：发现、开发与临床应用
Front Microbiol. 2023 Mar 7;14:1173906. doi: 10.3389/fmicb.2023.1173906. eCollection 2023.
5
Antibiotic Use and Treatment Outcomes among Children with Community-Acquired Pneumonia Admitted to a Tertiary Care Public Hospital in Nepal.尼泊尔一家三级护理公立医院收治的社区获得性肺炎儿童的抗生素使用情况及治疗结果
Trop Med Infect Dis. 2021 Apr 20;6(2):55. doi: 10.3390/tropicalmed6020055.
6
(p)ppGpp Metabolism and Antimicrobial Resistance in Bacterial Pathogens.细菌病原体中的（p）ppGpp代谢与抗菌耐药性
Front Microbiol. 2020 Oct 9;11:563944. doi: 10.3389/fmicb.2020.563944. eCollection 2020.
7
Antimicrobial Susceptibility Trends among Pathogens Isolated from Blood: A 6-Year Retrospective Study from a Tertiary Care Hospital in East Sikkim, India.从血液中分离出的病原体的抗菌药物敏感性趋势：一项来自印度锡金邦东部一家三级护理医院的6年回顾性研究。
J Lab Physicians. 2020 Mar;12(1):3-9. doi: 10.1055/s-0040-1712814. Epub 2020 Jun 11.
8
A review of animal health and drug use practices in India, and their possible link to antimicrobial resistance.印度动物健康和药物使用情况综述及其与抗微生物药物耐药性的可能联系。
Antimicrob Resist Infect Control. 2020 Jul 8;9(1):103. doi: 10.1186/s13756-020-00760-3.
9
Antimicrobial Resistance: Progress in the Decade since Emergence of New Delhi Metallo-β-Lactamase in India.抗微生物药物耐药性：自印度出现新德里金属β-内酰胺酶以来十年间的进展
Indian J Community Med. 2019 Jan-Mar;44(1):4-8. doi: 10.4103/ijcm.IJCM_217_18.
10
Genomic plasticity associated with antimicrobial resistance in .与抗菌药物耐药性相关的基因组可塑性。
Proc Natl Acad Sci U S A. 2019 Mar 26;116(13):6226-6231. doi: 10.1073/pnas.1900141116. Epub 2019 Mar 13.
PLoS Med. 2016 Mar 2;13(3):e1001974. doi: 10.1371/journal.pmed.1001974. eCollection 2016 Mar.
4
Antibacterial drug discovery in the resistance era.耐药时代的抗菌药物发现。
Nature. 2016 Jan 21;529(7586):336-43. doi: 10.1038/nature17042.
5
Multidrug evolutionary strategies to reverse antibiotic resistance.逆转抗生素耐药性的多药进化策略。
Science. 2016 Jan 1;351(6268):aad3292. doi: 10.1126/science.aad3292.
6
Understanding the mechanisms and drivers of antimicrobial resistance.理解抗菌药物耐药性的机制和驱动因素。
Lancet. 2016 Jan 9;387(10014):176-87. doi: 10.1016/S0140-6736(15)00473-0. Epub 2015 Nov 18.
7
Trends in Extended Spectrum Beta-Lactamase (ESBL) Producing Enterobacteriaceae and ESBL Genes in a Dutch Teaching Hospital, Measured in 5 Yearly Point Prevalence Surveys (2010-2014).在一家荷兰教学医院中，通过5次年度现患率调查（2010 - 2014年）测定的产超广谱β-内酰胺酶（ESBL）肠杆菌科细菌及ESBL基因的趋势。
PLoS One. 2015 Nov 3;10(11):e0141765. doi: 10.1371/journal.pone.0141765. eCollection 2015.
8
Antimicrobial stewardship programme (AMSP) practices in India.印度的抗菌药物管理计划（AMSP）实践。
Indian J Med Res. 2015 Aug;142(2):130-8. doi: 10.4103/0971-5916.164228.
9
The World Health Organization Global Action Plan for antimicrobial resistance.世界卫生组织抗微生物药物耐药性全球行动计划。
S Afr Med J. 2015 Apr 6;105(5):325. doi: 10.7196/samj.9644.
10
Molecular mechanisms of antibiotic resistance.抗生素耐药性的分子机制。
Nat Rev Microbiol. 2015 Jan;13(1):42-51. doi: 10.1038/nrmicro3380. Epub 2014 Dec 1.